Selected article for: "cc NC ND International license and low risk"
Author: Ingrid Arevalo-Rodriguez; Diana Buitrago-Garcia; Daniel Simancas-Racines; Paula Zambrano-Achig; Rosa del Campo; Agustin Ciapponi; Omar Sued; Laura Martinez-Garcia; Anne Rutjes; Nicola Low; Jose A Perez-Molina; Javier Zamora
Title: FALSE-NEGATIVE RESULTS OF INITIAL RT-PCR ASSAYS FOR COVID-19: A SYSTEMATIC REVIEW
  • Document date: 2020_4_21
    • ID: g8h6trql_30
    Snippet: We rated the certainty of the evidence about false-negative cases following the GRADE approach 180 for tests and strategies [22, 23] . We assessed the quality of evidence as high, moderate, low or very 181 low, depending on several factors including risk of bias, imprecision, inconsistency, indirectness, and 182 publication bias. We illustrate the consequences of the numerical findings in a population of 100 183 tested, according to three differe.....
    Document: We rated the certainty of the evidence about false-negative cases following the GRADE approach 180 for tests and strategies [22, 23] . We assessed the quality of evidence as high, moderate, low or very 181 low, depending on several factors including risk of bias, imprecision, inconsistency, indirectness, and 182 publication bias. We illustrate the consequences of the numerical findings in a population of 100 183 tested, according to three different prevalence estimates of the disease provided by the 184 stakeholders involved in this review. 185 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and grade approach: 1, 2
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and prevalence estimate: 1, 2
    • cc NC ND International license and strategy test: 1
    • evidence quality and grade approach: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • evidence quality and International license: 1, 2, 3, 4
    • evidence quality and prevalence estimate: 1, 2, 3, 4, 5, 6, 7
    • evidence quality and publication bias: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • evidence quality and strategy test: 1
    • evidence quality assess and grade approach: 1, 2, 3, 4, 5, 6, 7
    • evidence quality assess and prevalence estimate: 1
    • evidence quality assess and publication bias: 1, 2, 3
    • false negative case and grade approach: 1
    • grade approach and International license: 1, 2
    • grade approach and prevalence estimate: 1, 2, 3
    • grade approach and publication bias: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • grade approach and strategy test: 1
    • International license and prevalence estimate: 1, 2, 3, 4, 5
    • International license and strategy test: 1, 2, 3, 4